India’s Biological E. to manufacture Johnson & Johnson’s Covid vaccine
Multinational pharma big Johnson and Johnson together with Telangana-based Biological E. Limited will manufacture the Johnson & Johnson COVID-19 vaccine, which may enhance the nation’s general provides amid a scarcity.
In a press release, Johnson & Johnson stated, “We’re working around clock to develop & broadly activate manufacturing capabilities to supply vaccine worldwide.”
In April, Johnson and Johnson had utilized to India’s drug regulator in search of permission to conduct phase-3 scientific trial of its single-dose COVID-19 vaccine in India in addition to import licence.
ALSO READ: Pfizer, Moderna, Johnson and Johnson vaccines efficient towards B1617 variant of COVID-19
